Evaluation of the Million Hearts® Cardiovascular Disease Risk Reduction Model: Second Annual Report

Publisher: Washington, DC: Mathematica
Nov 30, 2019
Authors
Greg Peterson, Linda Barterian, Keith Kranker, Amanda Markovitz, Adam Rose, Rumin Sarwar, Allison Steiner, Leslie Conwell, Jia Pu, Michael Barna, David Magid, Kate Steward, Laura Blue, Dan Kinber, Precious Ogbuefi, and Nancy McCall

Key Findings:

  • 328 organizations participated in the model, half randomly assigned to the intervention group and half to the control group.
  • 71 percent of intervention group providers reported calculating CVD risk scores for at least half of their Medicare beneficiaries, compared to 36 percent of control group providers.
  • Within six months of enrollment, intervention group beneficiaries were 17 percent more likely than control group beneficiaries to start or intensify statin or anti-hypertensive therapy.
  • The all-cause mortality rate was 7 percent lower in the intervention group than the control group.

The Million Hearts Cardiovascular Disease (CVD) Risk Reduction Model tests whether providing targeted incentives to health care providers to reduce CVD risk lowers the incidence of first-time heart attacks and strokes among Medicare beneficiaries (ages 40-79 who have not had a previous heart attack or stroke). This report presents findings through evaluation year two of the five-year randomized trial. Findings include positive impacts on rates of providers calculating risk scores and of beneficiaries starting or intensifying statin or anti-hypertensive medications. Findings further include a 7 percent reduction in all-cause mortality.